In our study, we conducted a comprehensive assessment of FOXA1, revealing a potential role of FOXA1 as an indicator of patient prognosis and molecular mechanism of FOXA1 to promote EMT by regulating CTGF/TGF-β pathway in ovarian cancer. Here, CCN2 is linked to ovarian cancer.